0000899243-22-033322.txt : 20221007 0000899243-22-033322.hdr.sgml : 20221007 20221007201800 ACCESSION NUMBER: 0000899243-22-033322 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221005 FILED AS OF DATE: 20221007 DATE AS OF CHANGE: 20221007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dmytruk Mark E. CENTRAL INDEX KEY: 0001873507 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40097 FILM NUMBER: 221301867 MAIL ADDRESS: STREET 1: C/O SOARING EAGLE ACQUISITION CORP. STREET 2: 955 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc. CENTRAL INDEX KEY: 0001830214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 872652913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (877) 442-5362 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp. DATE OF NAME CHANGE: 20210210 FORMER COMPANY: FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp. DATE OF NAME CHANGE: 20201027 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-05 0 0001830214 Ginkgo Bioworks Holdings, Inc. DNA 0001873507 Dmytruk Mark E. C/O GINKGO BIOWORKS HOLDINGS, INC. 27 DRYDOCK AVENUE BOSTON MA 02210 0 1 0 0 See remarks Class A Common Stock 2022-10-05 4 M 0 618242 A 627344 D Class A Common Stock 2022-10-06 4 S 0 279255 3.25 D 348089 D Class B Common Stock 2022-10-05 4 M 0 618242 D Class A Common Stock 39891 D Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a "sell to cover" transaction. Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Excludes restricted stock units, which were previously reported as shares of Class B common stock on the Form 4 filed by the reporting person on March 14, 2022. Because the Issuer has the ability to settle such restricted stock units with shares of Class A common stock or cash upon vesting, restricted stock units will be reported separately from shares of Class B Common Stock in future reports. Chief Financial Officer /s/ Karen Tepichin, Attorney-in-Fact 2022-10-07